Personal tools
Log in

Skip to content. | Skip to navigation

Sections
You are here: Home Library Health Topics Collection Guidelines 18-Fluorodeoxyglucose positron emission tomography in the diagnosis and staging of lung cancer: a clinical practice guideline. Program in Evidence-based Care. NGC:006238
Document Actions

18-Fluorodeoxyglucose positron emission tomography in the diagnosis and staging of lung cancer: a clinical practice guideline. Program in Evidence-based Care. NGC:006238

Publication Details
Author(s):
  • AHRQ (US) - Agency for Healthcare Research and Quality
Country(ies) of application:
  • Canada
Language(s):
  • English
Type of Publication:
Guideline Clearing Report
Publication URL:
Open Publication URL in a new window
Publication Scope:
  • Assessment/diagnosis
Publication Status:
Published
Date of publication:
Apr 01, 2007
Due for Review:
-
Diseases / Conditions Addressed
MeSH Terms addressed:
  • Cancer / Neoplasms (C04)
    • Respiratory Tract Neoplasms (C04.588.894.797)
      • Lung Neoplasms (C04.588.894.797.520)
  • Diagnosis (E01)
    • Diagnostic Techniques and Procedures (E01.370)
      • Diagnostic Imaging (E01.370.350)
Guideline key questions
Page last updated: Jan 14, 2010

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.